Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2010
10/14/2010US20100261746 Pharmaceutical formulation
10/14/2010US20100261745 Pharmaceutical formulation
10/14/2010US20100261744 Pharmaceutical formulation
10/14/2010US20100261743 Novel seh inhibitors and their use
10/14/2010US20100261741 Quinazolinone T-Type Calcium Channel Antagonists
10/14/2010US20100261732 1, 2, 4 -triazole derivatives as serotonergic modulators
10/14/2010US20100261728 Trp-m8 receptor ligands and their use in treatments
10/14/2010US20100261724 Heterocycle phenyl amide t-type calcium channel antagonists
10/14/2010US20100261715 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
10/14/2010US20100261711 Selective anticonvulsant agents and their uses
10/14/2010US20100261709 Pyridazinone derivatives as parp inhibitors
10/14/2010US20100261708 Diazepane Compounds Which Modulate The CB2 Receptor
10/14/2010US20100261707 Thiadiazole derivatives for the treatment of neurodegenerative diseases
10/14/2010US20100261706 Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereof
10/14/2010US20100261696 Sulfonyl-azetidin-3-yl-methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
10/14/2010US20100261674 Therapeutic applications of fatty acid amide hydrolase inhibitors
10/14/2010US20100261670 Complexes of phosphate derivatives
10/14/2010US20100261669 Unit dosage for brain health
10/14/2010US20100261663 Compositions Containing Harpagoside and Paeoniflorin and Methods for Treatment of Conditions Associated with Pain, Inflammation, Arthritis and Symptoms Thereof
10/14/2010US20100261657 Use of a Granulin or a Granulin-Like Compound in the Therapy or Prophylaxis of Chronic Pains
10/14/2010US20100261656 Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin
10/14/2010US20100261647 Fusion proteins for delivery of erythropoietin to the cns
10/14/2010US20100261645 (carboxylalkylenephenyl)phenyloxamides, method for the production thereof and use of same as a medicament
10/14/2010US20100261644 (cyclopropylphenyl)phenyloxamides, method for the production thereof, and use of same as a medicament
10/14/2010US20100261643 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100260859 Controlled-release clozapine compositions
10/14/2010US20100260857 Enzyme delivery systems and methods of preparation and use
10/14/2010US20100260854 Granulate for the formulation of orodispersible tablets
10/14/2010US20100260844 Oral pharmaceutical dosage forms
10/14/2010US20100260843 Regeneration and repair of neural tissue using postpartum-derived cells
10/14/2010US20100260840 Orodispersible pharmaceutical composition of agomelatine
10/14/2010US20100260838 Method and composition for administering an nmda receptor antagonist to a subject
10/14/2010US20100260837 Bioavailable Capsule Compositions of Amorphous Alpha-(N-Sulfonamido)Acetamide Compound
10/14/2010US20100260835 Pharmaceutical composition
10/14/2010US20100260834 Abuse-deterrent drug formulations
10/14/2010US20100260825 Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches
10/14/2010US20100260816 Induction of immunological tolerance
10/14/2010US20100260810 Antidepressant dosage form
10/14/2010US20100260783 Antibody Specific Binding to A Beta Oligomer and the Use
10/14/2010US20100260758 In vivo modulation of neuronal transport
10/14/2010US20100260755 Ibudilast and immunomodulators combination
10/14/2010US20100260737 Combination between an isothiocyanate and levodopa for parkinson's disease treatment
10/14/2010US20100260733 Novel anti aging agents and methods to identify them
10/14/2010US20100260732 Role for sry in parkinson's disease
10/14/2010US20100260690 Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
10/14/2010US20100260688 New Formulation and Use Thereof
10/14/2010US20100260671 Compounds and methods for the diagnosis and treatment of amyloid associated diseases
10/14/2010US20100260670 ALTERNATIVE SPLICE VARIANT PATTERNS OF HUMAN TELOMERASE REVERSE TRANSCRIPTASE (hTERT) IN THYROID TUMORS TO DISTINGUISH BENIGN FROM MALIGNANT
10/14/2010US20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof
10/14/2010CA2758253A1 Control of concentric tubing direction
10/14/2010CA2758251A1 Serotonin and norepinephrine reuptake inhibitor
10/14/2010CA2758233A1 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
10/14/2010CA2758105A1 Indane derivatives
10/14/2010CA2757979A1 Controlled-release clozapine compositions
10/14/2010CA2757723A1 Method of predicting a predisposition to qt prolongation based on abcc2 gene sequence or product thereof
10/14/2010CA2757646A1 Method of predicting a predisposition to qt prolongation based on bai3 gene sequence or product thereof
10/14/2010CA2757368A1 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010CA2749253A1 Once-daily oral ir/cr pramipexole formulation
10/13/2010EP2239674A1 Method for classifying and treating physiologic brain imbalances using quantitative EEG
10/13/2010EP2239325A1 Virus growing in hypoxic cell or virus vector expressing gene therein
10/13/2010EP2239320A1 Nerve trunk cell propagation accelerator
10/13/2010EP2239269A1 Use of peptides derived from copolymer-1 as molecular weight markers
10/13/2010EP2239265A1 Crystalline cinnamide compounds or salts thereof
10/13/2010EP2239262A2 Fused ring heterocycle kinase modulators
10/13/2010EP2239254A1 Benzylpiperizine compound
10/13/2010EP2239253A1 Novel phenylpyrrole derivative
10/13/2010EP2238987A1 Sugar chain-related gene and use thereof
10/13/2010EP2238986A2 Sp35 antibodies and uses thereof
10/13/2010EP2238978A1 Pharmaceutical compositions containing an inclusion complex formed by disulfiram and a cyclodextrin, which can be used in the treatment of alcohol and cocaine dependence
10/13/2010EP2238976A1 Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof
10/13/2010EP2238141A1 Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of gsk3-beta
10/13/2010EP2238136A1 Monomaleate monohydrate salt of a 5ht1a receptor antagonist
10/13/2010EP2238131A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
10/13/2010EP2238130A1 Carboxamide compounds and their use as calpain inhibitors
10/13/2010EP2238126A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof
10/13/2010EP2238125A1 Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors
10/13/2010EP2238122A1 Preparation of sulfamide derivatives
10/13/2010EP2238117A1 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/13/2010EP2238111A1 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of -secretase (bace)
10/13/2010EP2237779A1 Benzothiazole and benzoxazole derivatives and methods of use
10/13/2010EP2237777A2 Compositions and methods for treating neurodegenerative diseases
10/13/2010EP2041133B1 Derivatives of imidazo [1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics
10/13/2010EP1891056B1 Novel compounds
10/13/2010EP1765381B1 Treatment of neurological disorders with haematopoietic growth factors
10/13/2010EP1532141B1 2-pyrrolidin-2-yl- [1,3,4]-oxadiazole derivatives and the use of the same as antidepressants
10/13/2010EP1499618B1 Furyl compounds
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010CN201602500U 一种保健枕 One kind Pillow
10/13/2010CN1969986B Ganoderma lucidum capsule for improving sleep and immunity, preparation method and use thereof
10/13/2010CN1931270B Sobering up and liver protecting Chinese medicine preparation and its preparation process
10/13/2010CN1879811B Chinese medicinal composition for treating epilepsy
10/13/2010CN1805939B Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
10/13/2010CN1799586B Cold treating capsule and its preparation method
10/13/2010CN1774281B Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
10/13/2010CN1646473B Novel curcumin analogues and uses thereof
10/13/2010CN1395581B Recombinant antibodies to human IL-1 beta
10/13/2010CN101861334A Cyclic receptor-associated protein (RAP) peptides
1 ... 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 ... 1833